Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data
The new findings, presented during a late-breaking presentation, focused on 110 PAD patients treated with Shockwave Medical's Javelin Peripheral IVL Catheter.
Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device
Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.
Pulmonary embolism thrombectomy use increases by more than 700%
Medicare claims submitted between 2017 and 2022 showed a 712% increase in thrombectomy for pulmonary embolism (PE) and a 137% increase in thrombectomy for deep vein thrombosis (DVT).
Cardiologist Peter Soukas becomes chief medical officer of carotid stent company
The company said the move will help it prepare for what is expected to be a rapid expansion of carotid stenting.
How to minimize bleeding risks after TAVR
Bleeding events remain a serious complication after TAVR. By identifying high-risk patients early and planning ahead, however, care teams can keep them to a minimum.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

Statins still effective in older stroke patients, reducing the risk of cardiovascular events and death

The study's authors aimed to learn more about an area where clinical evidence was lacking: statin therapy for stroke patients 80 years old and older.

Direct oral anticoagulants safer than warfarin for AFib patients with bioprosthetic heart valves

The analysis, published in the American Journal of Cardiology, focused on both the safety and effectiveness of these two treatment options.

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant.

USPSTF recommends against screening healthy adults for carotid artery stenosis

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said.

American Heart Association explores close ties between mental, cardiovascular health

Depression, chronic stress, anxiety and anger are all associated with a heightened risk of heart rhythm irregularities, stroke and other serious cardiovascular conditions.

What new research tells us about stroke mortality among men and women

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis.

New technique for battling blood clots uses nanodroplets, ultrasound imaging

The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.

Vascular & Endovascular

Shockwave Medical’s IVL catheter for peripheral lesions linked to positive 1-year data

Medtech startup co-founded by cardiologist seeks FDA clearance for new-look perfusion device

Pulmonary embolism thrombectomy use increases by more than 700%

Cardiologist Peter Soukas becomes chief medical officer of carotid stent company

How to minimize bleeding risks after TAVR